Laser Atherectomy Devices Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Laser atherectomy devices are advanced medical tools used in interventional cardiology and vascular surgery to remove blocked arteries and restore blood flow. Laser atherectomy offers several benefits, including minimally invasive treatment, precise plaque removal, and applicability to different types of arterial lesions. It requires specialized training and is typically performed by interventional cardiologists or vascular surgeons. Laser atherectomy can also treat multiple blockages in the same procedure and be performed under local anesthesia.

The “Global Laser Atherectomy Devices Market Analysis to 2028” is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the laser atherectomy devices Market with detailed market segmentation by application, end-user, and geography. The report provides key statistics on the market status of the leading laser atherectomy devices market players and offers key trends and opportunities in the market.

MARKET DRIVERS

Factors driving the laser atherectomy devices market growth are the increasing prevalence of peripheral artery disease, technology advancements in laser atherectomy devices, and increasing focus on outpatient and ambulatory settings. However, stringent regulatory policies and the absence of well-skilled surgeons are the factors restraining the laser atherectomy devices market growth.

Technology advancements in laser atherectomy devices are boosting market growth. With advancements in laser technology, the devices have become more sophisticated, allowing healthcare providers to precisely target and remove arterial blockages with minimal damage to surrounding tissues. These advancements have led to better patient outcomes, reduced procedure times, and increased patient satisfaction. As healthcare providers recognize the benefits of these advanced devices, the demand for laser atherectomy procedures has risen. with the development of laser atherectomy devices, physicians can perform less invasive procedures that allow for quicker recovery times and lower risk of complications. Patients prefer minimally invasive procedures because they offer faster recovery times and fewer complications. However, the Limited availability of skilled healthcare professionals is a key factor anticipated to hamper the laser atherectomy devices industry’s growth. These advancements have increased physician and healthcare facilities' adoption of laser atherectomy devices, leading to market growth. Thus, technological advancements in laser atherectomy devices are fueling the laser atherectomy devices market growth.

GLOBAL SEGMENTAL ANALYSIS

The global laser atherectomy devices market is segmented into application, end-user. Based on application the market is subsegmented as cardiovascular, peripheral vascular, and neurovascular. Based on end-user, the market is segmented into hospitals & surgical centers, ambulatory care centers, and others. Based on application, the peripheral vascular segment dominates the laser atherectomy devices market share. The rising prevalence of peripheral vascular disease (PVD), which refers to the narrowing or blockage of blood vessels outside the heart and brain, has propelled the growth of the laser atherectomy devices market. It is specifically designed to treat peripheral vascular disease (PVD) by removing plaque and restoring blood flow. With factors like an aging population and increasing risk factors such as diabetes and obesity contributing to the growing incidence of peripheral vascular disease (PVD), the demand for effective treatment options has increased. the laser atherectomy devices provide a minimally invasive approach, enabling precise plaque removal and vessel restoration, resulting in improved clinical outcomes. Technology advancements in these devices, including enhanced laser power, fiber optic delivery system, and imaging guidance, have further improved their safety and efficacy. The expanding prevalence of PVD has created significant market opportunities, driving the growth of laser atherectomy devices. Thus, the peripheral vascular is fueling the laser atherectomy devices market growth.

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides laser atherectomy devices market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & central America. The laser atherectomy devices market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and laser atherectomy devices market future trends. The report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & central America after evaluating political, economic, social and technological factors affecting the laser atherectomy devices market in these regions.

The North American laser atherectomy devices market is anticipated to be the highest growth in terms of revenue due to an increasing number of patients adopting atherectomy techniques, increased awareness about peripheral artery disease, and elevated healthcare infrastructure. The increased healthcare spending in developing countries is expected to be an excellent opportunity for market expansion.

Access Data

Have a question?

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

  Speak to Analyst

The report covers key developments in the laser atherectomy devices Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the laser atherectomy devices Market are anticipated to have lucrative growth opportunities in the future with the rising demand for laser atherectomy devices in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the laser atherectomy devices Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

• BOSTON SCIENTIFIC CORP
• CARDIOVASCULAR SYSTEMS
• MEDTRONIC
• PHILIPS
• TERUMO CORP
• AVINGER INC
• BD INTERVENTIONAL
• ANGIODYNAMICS
• ABBOTT LABORATORIES
• RA MEDICAL SYSTEMS

Recent Developments

• In August 2022, AngioDynamics, Inc. announced that it had been granted 510k clearance for an expansion of the indication on Auryon atherectomy system to include avascular thrombectomy.
• In January 2021, Cardiovascular Systems, Inc. announced that it has received CE Mark for its Diamondback 360 Coronary Orbital Atherectomy System (OAS) and ViperWire Advance Coronary Guide Wire with Flex Tip (ViperWire Advance with Flex Tip).
• In February 2022, RA Medical Systems, an atherectomy device manufacturer, announced that in a pivotal clinical trial to evaluate the safety and effectiveness of DABRA excimer laser for peripheral arterial disease treatment, enrolment has reached 95 patients.
• In October 2021. Becton, Dickinson, and Company (BD Interventional) announced that it had received FDA 510 (k) clearance for its Rotarex Atherectomy System to treat in-stent restenosis in peripheral arteries. BD thinks the clearance proves its responsibility for developing new technologies to combat this illness to provide physicians with a perfect solution that will give them an ideal treatment option for complicated lesions associated with Peripheral Arteritis.

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Access Data